Rvl Pharmaceuticals Plc (RVLP) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rvl Pharmaceuticals Plc  (NASDAQ: RVLP)

Rvl Pharmaceuticals Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Rvl Pharmaceuticals Plc in the second quarter 2023?
Rvl Pharmaceuticals Plc recorded a cumulative net loss of $-68 million during 12 months ending in the second quarter 2023, resulting in a negative return on equity (ROE) of -155.18%.

Within the Major Pharmaceutical Preparations industry 361 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2023 from 3355 to 3832.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Equity Change -72.1 % -42.43 % -33.41 % 25.2 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -68 -56 -52 -53 -57
Return On Equity (TTM) -155.18 % -103.57 % -83.5 % -77.72 % -87.11 %
RVLP's Total Ranking # 3832 # 3355 # 3821 # 1978 # 0
Equity (TTM) in Millions 16 40 51 69 59
Seq. Equity Change -59.19 % -21.71 % -25.46 % 17.15 % -15.79 %
Seq. Net Income Change - - - - -

Back to RVLP Management Effectiveness >> RVLP's 5 Years Annual ROE >> Compare RVLP ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 362
Sector # 752
Overall # 3832

Return On Equity Statistics
High Average Low
3.24 %
-58.5 %
-155.18 %
(Sep 30 2022)   (Jun 30 2023)





RVLP Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2017)
2018
Total Equity in Millions 51 77 94 115 436
Y / Y Equity Change -33.41 % -18.24 % -18.18 % -73.68 % -
Net Income in Millions -52 -65 -80 -271 -41
Y / Y Net Income Change - - - - -
Return On Equity -101.17 % -84.61 % -84.8 % -236.17 % -9.44 %

Back to RVLP Management Effectiveness >> RVLP's 5 Years Annual ROE >> Compare RVLP ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RVLP's' Return on Equity at Yahoo Finance
RVLP's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RVLP's Competitors
Subscribers only: Roe for Rvl Pharmaceuticals Plc's Suppliers
Subscribers only: Return On Equity for RVLP's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.